Clinical Characteristics and Outcomes of Juvenile and Adult Dermatomyositis

被引:44
作者
Na, Sang-Jun [1 ,2 ]
Kim, Seung Min [1 ]
Sunwoo, Il Nam [1 ]
Choi, Young-Chul [1 ]
机构
[1] Yonsei Univ, Coll Med, Brain Korea Project Med 21, Dept Neurol, Seoul 135720, South Korea
[2] Konyang Univ, Coll Med, Dept Neurol, Taejon, South Korea
关键词
Juvenile Dermatomyositis; Adult Dermatomyositis; Clinical Characteristics; Outcomes; ONSET POLYMYOSITIS-DERMATOMYOSITIS; COMPUTER-ASSISTED ANALYSIS; INFLAMMATORY MYOPATHIES; FEATURES; CANCER; CARCINOMA; PROGNOSIS; CHILDREN; DISEASE;
D O I
10.3346/jkms.2009.24.4.715
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dermatomyositis (DM) is an idiopathic inflammatory myopathy with bimodal onset age distribution. The age of onset is between 5-18 yr in juvenile DM and 45-64 yr in adult DM. DM has a distinct clinical manifestation characterized by proximal muscle weakness, skin rash, extramuscular manifestations (joint contracture, dysphagia, cardiac disturbances, pulmonary symptoms, subcutaneous calcifications), and associated disorders (connective tissue disease, systemic autoimmune diseases, malignancy). The pathogenesis of juvenile and adult DM is presumably similar but there are important differences in some of the clinical manifestations, associated disorders, and outcomes. In this study, we investigated the clinical characteristics and outcomes of 16 patients with juvenile DM and 48 with adult DM. This study recognizes distinctive characteristics of juvenile DM such as higher frequency of neck muscle involvement, subcutaneous calcifications, and better outcomes.
引用
收藏
页码:715 / 721
页数:7
相关论文
共 42 条
[1]   DERMATOMYOSITIS AND CARCINOMA - A CASE REPORT AND IMMUNOLOGICAL INVESTIGATION [J].
ALEXANDER, S ;
FORMAN, L .
BRITISH JOURNAL OF DERMATOLOGY, 1968, 80 (02) :86-+
[2]   PROGNOSTIC FACTORS IN POLYMYOSITIS - DERMATOMYOSITIS - A COMPUTER-ASSISTED ANALYSIS OF 92 CASES [J].
BENBASSAT, J ;
GEFEL, D ;
LARHOLT, K ;
SUKENIK, S ;
MORGENSTERN, V ;
ZLOTNICK, A .
ARTHRITIS AND RHEUMATISM, 1985, 28 (03) :249-255
[3]   POLYMYOSITIS AND DERMATOMYOSITIS .2. [J].
BOHAN, A ;
PETER, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (08) :403-407
[4]   POLYMYOSITIS AND DERMATOMYOSITIS .1. [J].
BOHAN, A ;
PETER, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (07) :344-347
[5]   COMPUTER-ASSISTED ANALYSIS OF 153 PATIENTS WITH POLYMYOSITIS AND DERMATOMYOSITIS [J].
BOHAN, A ;
PETER, JB ;
BOWMAN, RL ;
PEARSON, CM .
MEDICINE, 1977, 56 (04) :255-286
[6]  
Callen J P, 2002, Minerva Med, V93, P157
[7]   Dermatomyositis [J].
Callen, Jeffrey P. ;
Wortmann, Robert L. .
CLINICS IN DERMATOLOGY, 2006, 24 (05) :363-373
[8]   MALIGNANT LESIONS ASSOCIATED WITH DERMATOMYOSITIS [J].
CURTIS, AC ;
BLAYLOCK, HC ;
HARRELL, ER .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1952, 150 (09) :844-846
[9]  
Dalakas Marinos C., 1994, Current Opinion in Rheumatology, V6, P595, DOI 10.1097/00002281-199411000-00008
[10]  
Drake LA, 1996, J AM ACAD DERMATOL, V34, P824